[Inhibition of adherence of Corynebacterium diphtheriae to human buccal epithelium by glycoside hydrolases from marine hydrobiontes].
A possibility of adhesion inhibition of Corynebacterium diphtheriae to human buccal epithelium by glycoside hydrolases of marine hydrobiontes was investigated using alpha-galactosidase from marine bacterium Pseudoalteromonas sp. KMM 701, total enzyme preparation and beta-1,3-glucanase from marine fungi Chaetomium, total enzyme preparation and beta-1,3-glucanase from marine mollusk Littorina kurila, and total enzyme preparation from crystalline style of marine mollusk Spisula sachalinensis were used. The enzymes were added to test-tubes containing buccal epithelial cells and/or the toxigenic bacterial strain C. diphtheriae No 1129, v. gravis. All the investigated enzymes were able to abort C. diphtheriae adherence, to human buccal epithelocytes. Inhibition of adhesion was more pronounced in the case of treatment of epithelocytes with highly purified enzymes of marine hydrobiontes in comparison with total enzyme preparations. The significant inhibition of C. diphtheriae adhesion was observed when the enzymes were added to the epithelocytes with the attached microorganisms. The results obtained show that glycoside hydrolases of marine hydrobiontes degrade any carbohydrates expressed on cell surface of bacterium or human buccal epithelocytes, impair unique lectin-carbohydrate interaction and prevent the adhesion.
Zaporozhets
T S
TS
Makarenkova
I D
ID
Bakunina
I Iu
IIu
Burtseva
Iu V
IuV
Kusaĭkin
M I
MI
Balabanova
L A
LA
Zviagintseva
T N
TN
Besednova
N N
NN
Rasskazov
V A
VA
D000818:Animals; D001422:Bacterial Adhesion; D002597:Chaetomium / Q000201:enzymology; D003353:Corynebacterium diphtheriae / Q000502:physiology*; D003445:Crustacea / Q000201:enzymology; D004847:Epithelial Cells / Q000187:drug effects / Q000382:microbiology; D043326:Glucan 1,3-beta-Glucosidase / Q000302:isolation & purification / Q000494:pharmacology; D006026:Glycoside Hydrolases / Q000302:isolation & purification / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D009061:Mouth Mucosa / Q000187:drug effects* / Q000382:microbiology; D031161:Pseudoalteromonas / Q000201:enzymology; D049890:Spisula / Q000201:enzymology; D000519:alpha-Galactosidase / Q000302:isolation & purification / Q000494:pharmacology
D006026:Glycoside Hydrolases; D000519:alpha-Galactosidase; D043326:Glucan 1,3-beta-Glucosidase